Solara Active Pharma Sciences (NSE:SOLARAPP) Change In Receivables : ₹0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences Change In Receivables?

Solara Active Pharma Sciences's change in receivables for the quarter that ended in Sep. 2024 was ₹0 Mil. It means Solara Active Pharma Sciences's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Solara Active Pharma Sciences's change in receivables for the fiscal year that ended in Mar. 2024 was ₹1,782 Mil. It means Solara Active Pharma Sciences's Accounts Receivable declined by ₹1,782 Mil from Mar. 2023 to Mar. 2024 .

Solara Active Pharma Sciences's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹3,839 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Solara Active Pharma Sciences's Days Sales Outstanding for the three months ended in Sep. 2024 was 100.96.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Solara Active Pharma Sciences's liquidation value for the three months ended in Sep. 2024 was ₹-7,503 Mil.

Solara Active Pharma Sciences Change In Receivables Historical Data

The historical data trend for Solara Active Pharma Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Change In Receivables Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

678.00

-2,573.70

-145.50

-528.00

1,781.70

Solara Active Pharma Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Solara Active Pharma Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Solara Active Pharma Sciences (NSE:SOLARAPP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Solara Active Pharma Sciences's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3838.7	/	3469.5	*	91
=	100.96

2. In Ben Graham's calculation of liquidation value, Solara Active Pharma Sciences's accounts receivable are only considered to be worth 75% of book value:

Solara Active Pharma Sciences's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	180.7	-	12010.9	+	0.75 * 3838.7	+	0.5 * 2897.1
=	-7,503

Solara Active Pharma Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARAPP) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

890202:India SOLARA:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines